Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Morepen Laboratories Limited (NSE: MOREPENLAB), ISIN INE083A01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MOREPENLAB last traded at ₹99.05 (+7.37%), with a 52-week range of ₹33.05 to ₹150.70 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 35.65%, FIIs 3.43%, DIIs 1.70%, mutual funds 0.00%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.